Pryzm, a Government Market Intelligence and Relationship Management platform, announced on Tuesday a strategic collaboration ...
Two-Day Conference will Examine Future of AI and Intelligent Systems; Join Keynotes from Synopsys CEO and OpenAI Head of Hardware Via Livestream SNUG Silicon Valley brings together Synopsys users and ...
Lynx, the leader in delivering solutions for the Mission Critical Edge, announced today that its LYNX MOSA.ic operating environment has been selected by Bell Textron Inc., a Textron company, to ...
Insiders allege Capri Holdings CEO John D. Idol has failed big name fashion brands, including Jimmy Choo: “He’s taken the heart out of them.” ...
HTX Research, the research arm of HTX Group, has released an in-depth report titled, "dTAO and the Evolution of Bittensor: ...
Through the results of a unique technical collaboration between ARM and Synopsys, the process used by ARM licensees to port synthesizable ARM® microprocessor cores to their chosen technologies, has ...
Star Trek: Khan is produced by CBS’ Eye Podcast Productions Inc. CBS Studio’s podcasting arm; Secret Hideout; and Roddenberry Entertainment. Executive producers include Alex Kurtzman ...
December 31, 2024, with projected cash runway into late 2027 SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company ...
DENALI Part 1b is a Phase 2 single-arm study that evaluated azenosertib monotherapy at ... Zentalis ® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3) ...
With a complete high-consistency rubber injection molding cell, R.D. Abbott Co. Inc., Arburg GmbH and ACH Solution showcased ...
The CPU is an integrated quad-core Arm® A53 processor with Neon™ extensions ... MaxLinear, the MaxLinear logo, any other MaxLinear trademarks are all property of MaxLinear, Inc. or one of MaxLinear's ...
EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...